Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

381 recalls, newest first

Class II · Moderate risk

China-Gel White

CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.

Ongoing cGMP deviation China Gel Inc NDC 76305-301-02 D-0789-2021
Class II · Moderate risk

CHINA_GEL (Camphor 3.00%, Menthol 5.00%)

CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.

Ongoing cGMP deviation China Gel Inc NDC 76305-300-13 D-0788-2021
Class II · Moderate risk

Genesis Hand Sanitizer Gel

CGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.

Ongoing cGMP deviation Genesis Partnership Company SA NDC 74484-002-04 D-0039-2021
Class II · Moderate risk

Genesis Hand Sanitizer Gel

CGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.

Ongoing cGMP deviation Genesis Partnership Company SA NDC 74484-002-02 D-0038-2021
Class II · Moderate risk

Panagel Hand Sanitizer

CGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.

Ongoing cGMP deviation Genesis Partnership Company SA NDC 78384-001-04 D-0037-2021
Class III · Low risk

Ranitidine Tablets USP

CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.

Ongoing cGMP deviation AuroMedics Pharma LLC NDC 55910-092-79 D-0166-2020
Class II · Moderate risk

Repaskin 30

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0010-1 D-0849-2016
Class II · Moderate risk

Repaskin 50

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0011-1 D-0848-2016

Recalls by year